Search Results 3361-3370 of 17049 for STD Testing Stigma

1. A Study Of AAVB-039 In Participants With Stargardt Disease (STGD1) - Mayo Clinic

   The purpose of the 039-101 study is to evaluate the safety and tolerability of a single subretinal injection of AAVB-039 in participants with Stargardt disease ...

2. Study Of Tirabrutinib Vs Rituximab/Temozolomide For Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) - Mayo Clinic

   The purpose of this clinical trial is to evaluate efficacy and safety of tirabrutinib alone compared with rituximab and temozolomide (R-TMZ) combination therapy ...

3. A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled By Second Generation H1-antihistamines - Mayo Clinic

   A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled By ...

4. Comparative Effectiveness Of Different Techniques For Repeat Ablation Of Atrial Fibrillation - Mayo Clinic

   Atrial fibrillation (AF) is the most common type of irregular heartbeat doctors see. People with AF sometimes have a procedure called an ablation to help get ...

5. A Study Of Icotrokinra In Participants With Moderately To Severely Active Crohn's Disease - Mayo Clinic

   About this study. The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with ...

6. A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

   This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...

7. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) In The Treatment Of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). - Mayo Clinic

   About this study. A global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of ...

8. A Phase I/II Study Of AZD4512 Monotherapy Or In Combination With Anticancer Agents In Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   This is a Phase I/II open-label, global multicenter study to evaluate the safety and efficacy of AZD4512 monotherapy or in combination with other anticancer ...

9. A Study to Evaluate Gene Therapy to Treat Neovascular Age-related Macular Degeneration - Mayo Clinic

   The primary objective of this study is to evaluate mean change in best-corrected visual acuity (BCVA) of RGX-314 relative to ranibizumab at Week 38. Second ...

10. Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure - Mayo Clinic

    About this study. The primary objective of this Phase 2 study is to evaluate the efficacy and safety of a single antegrade intracoronary artery infusion of ...